CCNE1 and ovarian endometrioid adenocarcinoma: Similar findings were reported by Wiegand et al. [33], who noted that PIK3CA and ARID1A are more frequently mutated in clear cell and endometrioid ovarian cancers, which are subtypes that generally lack CCNE1 amplification.